Immune Therapeutics Revises and Resends Proxy Statement

NEXT STORY
Vaxil Announces Private Placement
PREV STORY
Catalyst Psychiatry Now Offering Mental Health Technology for Patients with Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD) in Corvallis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MorphoSys to Present Clinical Trial Data on Proprietary Programs at Upcoming ASCO Annual Meeting 2016

MARTINSRIED / MUNICH, Germany, May 19, 2016 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; ...

author_avatar
NASDAQ Market News

Corvus Pharmaceuticals Presents Updated Data from Mupadolimab (Anti-CD73) Phase 1/1b Clinical Trial at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

author_avatar
NASDAQ Market News

Neovacs announces the full results of its Phase IIb Clinical study of IFNalpha Kinoid in lupus – 13th International Lupus Congress 2019

author_avatar
NASDAQ Market News